Document is current
Any future updates will be listed below
-
Authors
Mouraux, Charlotte https://orcid.org/0000-0001-9569-9229
Dangouloff, Tamara
Poleur, Margaux
Mackels, Laurane
Vanden Brande, Laura
Daron, Aurore
Servais, Laurent
Maertens de Noordhout, Alain
Delstanche, Stéphanie
-
Funding
Funding for this research was provided by:
Fonds De La Recherche Scientifique - FNRS (MSc, a Ph.D of the Fund for Scientific Research)
- License Information
-
More Information
Article History
Received: 12 July 2024
Accepted: 28 July 2025
First Online: 29 August 2025
Declarations
:
: This project was approved by the Ethics Committee of the Citadelle Hospital of Liège on Oct 19, 2023, with the reference number “JL/rc/2093”. Written informed consent was not necessary for this cross-sectional noninterventional study. We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.
: Not applicable.
: S.D. reported disclosures as she was a consultant for Alexion, Alnylam, Argenx, Biogen, Roche, UCB, Janssen Pharmaceuticals and Amikus. T.D. has given lectures sponsored by Biogen, Novartis, and Roche. LS has given vonsultancy/part of the board for Biogen, Novartis, Roche, Scholar Rock, NMD bipharma, BioHaven, Biomarin, Dyne, Wave, Avidity, Entrada, Pfizer, RegenexBio, Italfarmaco and Santhera.
